Astellas Pharma Inc. et al v. Xellia Pharmaceuticals ApS et al
| Astellas Pharma Inc., Astellas US LLC and Astellas Pharma US, Inc. |
| Xellia Pharmaceuticals ApS and Xellia Pharmaceuticals, Inc. |
| 1:2018cv01818 |
| November 19, 2018 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 23, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC: For Xellia Pharmaceuticals, Inc. waiver sent on 11/21/2018, answer due 1/22/2019. (Blumenfeld, Jack) |
| Filing 6 WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC: For Xellia Pharmaceuticals ApS waiver sent on 11/21/2018, answer due 1/22/2019. (Blumenfeld, Jack) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC. (lak) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,774,104 B1. (lak) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/9/2018. Date of Expiration of Patent: 1/8/2021.Thirty Month Stay Deadline: 1/8/2021. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Xellia Pharmaceuticals ApS, Xellia Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2507287.) - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(lak) |
| Summons Issued with Magistrate Consent Notice attached as to Xellia Pharmaceuticals ApS on 11/19/2018; Xellia Pharmaceuticals, Inc. on 11/19/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
